These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2963524)

  • 1. Effects of celiprolol on serum lipids in systemic hypertension.
    Herrmann JM; Bischof F; Von Heymann F; Freischuetz G; Burghagen H
    Am J Cardiol; 1988 Feb; 61(5):41C-44C. PubMed ID: 2963524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
    Herrmann JM; Mayer EO
    Am Heart J; 1988 Nov; 116(5 Pt 2):1416-21. PubMed ID: 2903652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
    Fogari R; Zoppi A; Tettamanti F; Malamani G; Pasotti C
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
    Malminiemi K
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):295-304. PubMed ID: 7662596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
    van Hoof R; Desager JP; Harvengt C; Fagard R; Lijnen P; Peerenboom P; Staessen J; Thijs L; Van Mieghem W; Amery A
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):268-73. PubMed ID: 1381018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of celiprolol on cardiovascular reactivity to laboratory stressors in patients with hypertension.
    Cardillo C; Degen C; De Felice F; Folli G
    Clin Pharmacol Ther; 1992 May; 51(5):555-61. PubMed ID: 1534042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
    Lucarini AR; Salvetti A
    Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins.
    Hunninghake DB
    Am Heart J; 1991 Feb; 121(2 Pt 2):696-701. PubMed ID: 1671189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
    Dujovne CA; Eff J; Ferraro L; Goldstein RJ; Gotto AM; Hall WD; Harris WS; Held SJ; Herd A; Hunninghake DB
    Am J Cardiol; 1993 Nov; 72(15):1131-6. PubMed ID: 8237801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antihypertensive effects of celiprolol and acebutolol.
    Terziivanov D; Vlahov V; Belovezhdov N; Gerova Z
    Eur J Clin Pharmacol; 1988; 34(2):125-8. PubMed ID: 2968268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
    Parati G; Pomidossi G; Casadei R; Ravogli A; Trazzi S; Mutti E; Mancia G
    J Int Med Res; 1988; 16 Suppl 1():52A-61A. PubMed ID: 2975612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats.
    Andrzejczak D; Górska D
    Pharmacol Rep; 2014 Feb; 66(1):68-73. PubMed ID: 24905309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.
    Kimura S; DeQuattro V; Hernandez PH; Lee DD
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):751-4. PubMed ID: 2971310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol.
    Herrmann JM; Bischof F; Von Heymann F; Mayer EO; Freischuetz G; Burghagen H
    Am J Cardiol; 1988 Feb; 61(5):55C-56C. PubMed ID: 2963527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.